Vaccines against coronavirus? | Departments

A team of scientists has developed a new vaccine for several coronaviruses, yet to be discovered.

The project, led by scientists from the universities of Oxford, Cambridge and the California Institute of Technology, aims to introduce an “early” vaccine before the next potential pandemic emerges.

The test dose, tested only in mice, trains the immune system to recognize parts of various coronaviruses, including “Covid,” “SARS,” and “MERS,” especially since current vaccines train the immune system to target a specific type of virus. Viruses.

The vaccine works by using a tiny ball of proteins called a “quadruple nanocage” to bind to what scientists later called “protein superglue,” substances that stimulate the body’s immune response, helping it fight pathogens.

The resulting vaccine helps the immune system recognize parts of 8 coronaviruses, some of which are currently only found in wild bats but could (in theory) spread to humans in the future.

Also Read: “Pfizer”: Cancer Is The “New Covid”

Tests showed that the vaccine helped mice fight off SARS-Cov-1, the pathogen that caused the 2003 SARS outbreak, although the vaccine contained no samples specifically of that virus.

Rory Hills, a graduate researcher in the Department of Pharmacology at the University of Cambridge and first author of the study, said: “We are focused on developing a vaccine that will protect us against the next coronavirus pandemic and different types of coronaviruses.”

04/28/2024 Professor Fukushima, Japan’s senior oncologist, denounces mRNA vaccines as essentially murder. As a scientist and physician, he is deeply concerned and says that vaccines cause turbo cancer and excess deaths. Professor Fukushima believes the new coronavirus… pic.twitter.com/7J7BP0OqHr

— Forestcui07 (@forestcui07) May 7, 2024

Professor Mark Howarth, one of the study’s senior authors, said the results could be a starting point for producing new vaccines faster than those developed in the dark days of the Covid pandemic.

Also Read: Iran Exports 4 Million Doses of Corona Vaccines

Scientists hope that clinical trials of the new vaccine will begin as early as 2025

Yesterday, Pfizer CEO Albert Borla revealed ambitious plans to move into the “cancer treatment market” after the “Covid-19” pandemic and global demand for vaccines has slowed, according to Fox Business.